Seppo W. Langer

Medicin og biovidenskab

1. 64Cu-DOTATATE 100%
2. Anthracyclines 16%
3. Carcinoid Tumor 24%
4. Dexrazoxane 20%
5. Drug Therapy 33%
6. Edotreotide 29%
7. Exercise 35%
8. Feasibility Studies 16%
9. Fluorodeoxyglucose F18 30%
10. Ga(III)-DOTATOC 52%
11. Ganglioneuroblastoma 23%
12. Gastrointestinal Tract 15%
13. Lung Neoplasms 74%
14. Multiple Hamartoma Syndrome 21%
15. Neoplasms 26%
16. Neuroendocrine Carcinoma 98%
17. Neuroendocrine Tumors 92%
18. Non-Small Cell Lung Carcinoma 22%
19. Octreotide 19%
20. Pancreatic Carcinoma 17%
21. Positron Emission Tomography Computed Tomography 24%
22. Positron-Emission Tomography 18%
23. Precision Medicine 15%
24. Progression-Free Survival 18%
25. Prospective Studies 19%
26. Rehabilitation 44%
27. Small Cell Lung Carcinoma 37%
28. somatostatin receptor 2 27%
29. Survival 25%
30. Therapeutics 19%
31. Topotecan 20%
32. Type II DNA Topoisomerase 18%